CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Mayer Arie Director | Grant or award | +6,000 | 6,000 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award | +150,000 | 916,481 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Shares withheld for taxes | −48,752 | $13.89 | $677K | 867,729 |
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award | +63,000 | 930,729 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy | +107,000 | 107,000 | ||
| 2022-01-03 | Sank Leonard Director | Grant or award | +6,000 | 6,000 | ||
| 2022-01-03 | Sank Leonard Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2022-01-03 | Mayer Arie Director | Grant or award | +6,000 | 9,000 | ||
| 2022-01-03 | Mayer Arie Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-11-01 | Mayer Arie Director | Sale | −3,000 | $25.60 | $77K | 0 |
Page 9 of 9 · 170 trades